This content is machine translated Incretin-based therapies for type 2 diabetes Evolution of therapy options continues Incretin mimetics are an attractive treatment option, particularly for the subgroup of overweight type 2 diabetics, as they not only have glucose-lowering effects, but have also demonstrated clinical benefits in…
View Post 4 min This content is machine translated Pharmacotherapy for people over 80 A case of age discrimination? SGLT2 inhibitors and GLP1 receptor agonists have emerged as the drugs of first choice in the guidelines for type 2 diabetes. Sulfonylureas and insulin, on the other hand, were deprioritized…
View Post 5 min This content is machine translated Heart failure and type 2 diabetes SGLT-2-i now recommended for the entire LVEF spectrum Based on data from large clinical trials, it is currently recommended that all patients with diabetes and chronic heart failure – regardless of left ventricular ejection fraction – are treated…
View Post 5 min This content is machine translated Diabetic neuropathy and retinopathy How risky are SGLT2i and GLP1-RA? Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP1-RA) play an important role in diabetes therapy. However, their effect on diabetic neuropathy and retinopathy is not clear.…
View Post 5 min This content is machine translated Chronic wounds State-of-the-art wound management: pioneering innovations Personalized medicine and technological innovations are among the most important current trends in wound diagnostics and treatment. In the field of stage-appropriate wound care, tissue engineering and smart dressings, for…
View Post 4 min This content is machine translated SGLT2i for heart failure HF prevalence in diabetes patients is underestimated in everyday clinical practice SGLT2 inhibitors can significantly reduce the risk of hospitalization for heart failure (HF) and death from cardiovascular causes in patients with diabetes and HF. However, the diagnosis of HF is…
View Post 6 min This content is machine translated Cold plasma for chronic wounds Impressive evidence base of effects that promote wound healing Numerous clinical studies have shown that cold atmospheric pressure plasma has great potential for treating poorly healing and chronic wounds. It is an innovative method to accelerate wound healing. In…
View Post 5 min This content is machine translated Closed-loop systems Remains effective even after one year There are only a few real-world studies on people who use closed-loop systems (CLS). And when they do exist, they usually only use one CLS model. A Spanish study group…
View Post 5 min This content is machine translated Venous leg ulcer Evaluation of innovative therapy methods Ulcus cruris venosum is the most severe form of chronic venous insufficiency. Despite gold standard therapy using compression and phase-adapted hydroactive wound treatment, it is not uncommon for patients with…
View Post 6 min This content is machine translated Type 1 diabetes: early detection and intervention Innovative approaches – what are the new beacons of hope? Type 1 diabetes is the most common metabolic disease in children and adolescents. Nowadays, this autoimmune disease can be diagnosed well before clinical manifestation. This enables a “window of opportunity”…
View Post 7 min This content is machine translated Androgenetic alopecia Evidence-based treatment – an overview of the most common treatment options Nowadays, there is a wide range of treatment options for androgenetic alopecia (AGA). Topical preparations with the active ingredient minoxidil and the oral 5-α-reductase inhibitors finasteride and dutasteride are among…
